Orbis Allan Gray’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
Other funds holding NAMS
DFO
Orbis Allan Gray's NAMS Position: Q3 2026 in Review
Orbis Allan Gray increased its NewAmsterdam Pharma (NAMS) stake by 115% in Q3 2026, buying an estimated $55.7M and bringing the position to 3,760,821 shares worth $91.5M. The position accounts for 0.3% of the portfolio, ranked #58.
Orbis Allan Gray first reported a position in NAMS in Q2 2026 and has held it in 2 quarters since. 183 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.
- Orbis Allan Gray held 3,760,821 shares of NewAmsterdam Pharma worth $91.5M as of Q3 2026.
- Orbis Allan Gray bought 2,013,194 NewAmsterdam Pharma shares in Q3 2026, an estimated $55.7M.
- NewAmsterdam Pharma made up 0.3% of Orbis Allan Gray's portfolio in Q3 2026, its #58 holding.
- Orbis Allan Gray first reported a position in NewAmsterdam Pharma in Q2 2026 and has held it in 2 quarters since.
- 183 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.
Based on Orbis Allan Gray's 13F filing for Q3 2026, filed 16 Nov 2026.